Establishment of the cell line, HeLa-CD14, transfected with the human CD14 gene

Oncology Letters

Volumn 3, Issue 4, 2012, Pages 871-874

  Ning, Bo Tao ^a   Tang, Yong Min ^a  

^a CHILDREN S HOSPITAL OF ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

CD14; HeLa; Transfectant

Indexed keywords

CD14 ANTIGEN; ENDONUCLEASE; LIGASE; MESSENGER RNA; PLASMID DNA;

ARTICLE; CONTROLLED STUDY; EUKARYOTE; FLUORESCENCE; GENE EXPRESSION; GENE SEQUENCE; GENETIC TRANSFECTION; HELA CELL; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MOLECULAR CLONING; RECOMBINANT PLASMID; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UTERINE CERVIX CANCER;

EID: 84856835421     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2012.557     Document Type: Article

References (16)

1. Mason D, Simmons D, Buckley C, et al: Leukocyte Typing VII. Oxford University Press Inc, New York, 2002.
2. Poussin C, Foti M, Carpentier JL and Pugin J: CD14-dependent endotoxin internalization via a macropinocytic pathway. J Biol Chem 273: 20285-20291, 1998.
3. Botling J, Oberg F, Torma H, Tuohimaa P, Blauer M and Nilsson K: Vitamin D3-and retinoic acid-induced monocytic differentiation: interactions between the endogenous vitamin D3 receptor, retinoic acid receptors, and retinoid X receptors in U-937 cells. Cell Growth Differ 7: 1239-1249, 1996.
4. Suzuki M, Furugen Y, Miyazaki R, Yamamoto T and Takada M: Sequential changes of HPV DNA, the expression of EGF-R and CD-14, and histopathological findings in HPV infected benign epithelium and dysplastic lesions of the uterine cervix. Nihon Sanka Fujinka Gakkai Zasshi 44: 805-812, 1992 (In Japanese).
5. Sambrook J and Russell DW: Molecular Cloning: A Laboratory Manual, 3rd edition. Cold Spring Harbor Laboratory Press, New York, 2001.
6. Kirkland TN and Viriyakosol S: Structure-function analysis of soluble and membrane-bound CD14. Prog Clin Biol Res 397: 79-87, 1998.
7. Triantafilou M, Sawyer D, Nor A, Vakakis E and Triantafilou K: Cell surface molecular chaperones as endogenous modulators of the innate immune response. Novartis Found Symp 291: 74-79; discussion 79-85, 137-140, 2008.
8. Dziarski R, Viriyakosol S, Kirkland TN and Gupta D: Soluble CD14 enhances membrane CD14-mediated responses to peptidoglycan: structural requirements differ from those for responses to lipopolysaccharide. Infect Immun 68: 5254-5260, 2000.
9. Ichimura H, Sakashita N, Iida T, et al: Differentiation of a cell line of human cervical argyrophil small cell carcinoma to macrophage lineage cells. Jpn J Cancer Res 90: 523-529, 1999.
10. + Th1 cells. J Immunol 187: 1157-1165, 2011.
11. Baldini M, Lohman IC, Halonen M, Erickson RP, Holt PG and Martinez FD: A polymorphism* in the 5' flanking region of the CD14 gene is associated with circulating soluble CD14 levels and with total serum immunoglobulin E. Am J Respir Cell Mol Biol 20: 976-983, 1999.
12. Ferrero E, Hsieh CL, Francke U and Goyert SM: CD14 is a member of the family of leucine-rich proteins and is encoded by a gene syntenic with multiple receptor genes. J Immunol 145: 331-336, 1990.
13. Capes-Davis A, Theodosopoulos G, Atkin I, et al: Check your cultures! A list of cross-contaminated or misidentified cell lines. Int J Cancer 127: 1-8, 2010.
14. Rahbari R, Sheahan T, Modes V, Collier P, Macfarlane C and Badge RM: A novel L1 retrotransposon marker for HeLa cell line identification. Biotechniques 46: 277-284, 2009.
15. Masters JR: HeLa cells 50 years on: the good, the bad and the ugly. Nat Rev Cancer 2: 315-319, 2002.
16. Yoon YG and Koob MD: Selection by drug resistance proteins located in the mitochondria of mammalian cells. Mitochondrion 8: 345-351, 2008.